TRUSTED IDENTITIES IN BLOCKCHAIN APPS
SHOWN TO WORK
-- To Benefit Healthcare and Pharma --
Tenafly, N.J. (April 25, 2017) -- A recently completed proof of concept study demonstrates that robust identity trust can be integrated with blockchain technology. This development has significant implications for the use of distributed electronic ledgers (i.e. blockchain) for pharmaceutical, healthcare and other applications.
Expert Tells House Committee: "Healthcare Cybersecurity is Worse Than Reported"
Tenafly, N.J. (April 5, 2017) -- "Cybersecurity in the healthcare industry is far worse than what is reported," the Subcommittee on Oversight and Investigations of the House Committee on Energy and Commerce learned yesterday from Terence M. Rice, Vice President and Chief Information Security Officer (CISO) at Merck & Co., Inc. Solving the problem will require public-private collaboration and transparency.
Global e-Identity Trust Ecosystem To Use
Single, Trusted Cyber Identity
Tenafly, N.J. (March 22, 2017) -- For the first time, Internet users will have a single cyber identity that can access a broad range of partners and applications in health care and the life sciences without compromising security or patient data.
mClinical Technology Leader, Parallel6,
Joins SAFE-BioPharma Association
TEANECK, N.J. (January 10, 2017) -- Parallel6™, the leader in mClinical technologies for improving patient enrollment, engagement, and management of clinical trials worldwide, has joined SAFE-BioPharma Association.
SAFE-BioPharma Partnership Named Winner
of HHS "Move Health Data Forward Challenge"
TEANECK, N.J. (November 7, 2016) – The Department of Health and Humans Services’ Office of the National Coordinator for Health Information Technology (ONC) named a proposal from SAFE-BioPharma, Resilient Network Systems and WebShield, Inc. as a Phase 1 winner of the Move Health Data Forward Challenge.
SAFE-BioPharma Publishes New Cybersecurity Guidelines -- Organization Also Issues Animated Video
TEANECK, N.J. (October 20, 2016) – On the occasion of National Cybersecurity Awareness Month, SAFE-BioPharma Association has issued new and comprehensive guidelines addressing cyber-identity authentication and uses of digital signatures.
VASCO MYDIGIPASS Gains SAFE-BIOPHARMA Full-Service Credential Service Provider Certification
OAKBROOK TERRACE, IL and TENAFLY, NJ – August 10, 2016 -- VASCO Data Security International, Inc. (NASDAQ: VDSI), a global leader in digital solutions including identity, security and business productivity, announced today that it has become a certified full-service Credential Service Provider in the SAFE-BioPharma Trust Framework, a unit of the global SAFE-BioPharma™ IT security standard used in the life sciences.
VASCO Brings Trusted Digital Identities to the Healthcare Community with launch of Integrated Identity Proofing, Credentialing and Authentication Solution:
MYDIGIPASS for Healthcare ensures EPCS compliance for prescribers and offers enhanced security for access to EHR/EMR applications and patient portals
OAKBROOK TERRACE, IL -- July 21, 2016 -- VASCO Data Security International, Inc. (NASDAQ: VDSI), a global leader in authentication, electronic signatures, and identity management announced today the introduction of MYDIGIPASS™ for Healthcare, a comprehensive solution for healthcare organizations and vendors of health IT applications, such as electronic health record (EHR/EMR), electronic prescribing (eRx) and patient portal applications.
Transatlantic Alliance: TeleTrusT European Bridge CA (EBCA) and SAFEBioPharma Bridge CA (SBCA) become partners
Berlin, May 19, 2016 - The IT Security Association Germany (TeleTrusT) and the US organization SAFEBioPharma have recently established a transatlantic alliance for secure communication.
Foxit PhantomPDF Certified Compliant with SAFE-BioPharma® Digital Signature Standard
FREMONT, Calif. (May 3, 2016)—Foxit Software, a leading software provider of fast, affordable, and secure PDF solutions, today announced that Foxit PhantomPDF has been certified compliant with the SAFE-BioPharma® global digital identity standard.
SAFE-BioPharma Standard Assures Trust in Identity Credentials Used for TransCelerate Shared Investigator Platform
TENAFLY, N.J. (MARCH 29, 2016) – Every digital identity credential used to access and participate in the TransCelerate Shared Investigator Platform will comply with the global digital identity standard developed by SAFE-BioPharma Association.
SAFE-BIOPHARMA TO PARTICIPATE WITH ETSI IN SECURING GLOBAL IT INFRASTRUCTURE
TENAFLY, N.J. (DECEMBER 2, 2015) – The European Telecommunications Standards Institute (ETSI) has invited SAFE-BioPharma Association to participate in advancing their mutual interests to establish a standardized, secure and trusted global identity management and digital signature infrastructure.
EXOSTAR CERTIFICATE AUTHORITY DEEMED SHA-2 COMPLIANT BY SAFE-BIOPHARMA ASSOCIATION FOR LIFE SCIENCE AND HEALTHCARE IDENTITY CREDENTIALS
TEANECK, N.J. (NOVEMBER 4, 2015) – Exostar, a provider of secure cloud-based solutions that improve identity access management, is now certified by SAFE-BioPharma Association to issue SHA-2 compliant public key infrastructure (PKI) digital certificates for use in the life sciences and healthcare.
SBP DIGITAL TRUST CONSULTING LAUNCHES WEBSITE
Centralized Resource for Security, Identity and Access Management Expertise
TEANECK, N.J. (SEPTEMBER 24, 2015) – The new website for SBP Digital Trust Consulting is a resource for biopharmaceutical managers seeking expert guidance for a range of IT issues, including establishing secure global collaborations, improving workflows, and meeting international regulatory IT requirements.
Protection Against IRS and OPM-Type Hacks Available to Government Agencies but Not Always Used
TEANECK, N.J. (JULY 14, 2015) – Multi-factor authentication -- a security protection required by US government standards -- could have prevented the recent Internal Revenue Service (IRS) and Office of Personnel Management (OPM) security breaches that have exposed the personal information of millions of citizens to hackers, spies and cyber-criminals.
Exostar and SIGNiX Partner to Deliver Secure, Compliant Digital Signature Solution to Life Science and Healthcare
HERNDON, VA, and CHATTANOOGA, TN, June 16, 2015 – Exostar, an innovative information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, and SIGNiX, the leading provider of Independent E-Signatures™, today announced a relationship that brings SIGNiX’s digital signature solution to Exostar’s life science and healthcare communities.
SAFE-BIOPHARMA INTRODUCES CYBER SECURITY CONSULTING SERVICE FOR LIFE SCIENCE AND HEALTHCARE COMPANIES
TEANECK, N.J. (APRIL 23, 2015) – SAFE-BioPharma Association today announced creation of SBP Digital Trust Consulting, a resource of internationally recognized identity and access management (IAM) policy and technical experts for life science and healthcare companies seeking to develop improved cyber security strategies.
INCYTE JOINS SAFE-BIOPHARMA ASSOCIATION
TEANECK, N.J. (APRIL 15, 2015) – SAFE-BioPharma Association (www.safe-biopharma.org), the non-profit industry coalition responsible for the on-going development and implementation of the SAFE-BioPharma® digital identity and signature standard, today announced that Incyte Corporation has joined SAFE-BioPharma.
TransUnion Approved by
SAFE-BioPharma Trust Framework
TEANECK, NJ (MARCH 25, 2015) -- TransUnion, a leading global provider of information and risk management solutions, has been approved as an Identity Manager under SAFE-BioPharma FICAM Trust Framework 2.0.
SAFE-BioPharma Association Gives DocuSign DTM 'Clean Bill of Health'
SAN FRANCISCO—March 18, 2015—SAFE-BioPharma Association, the global industry standard for digital trust, announced that DocuSign, Inc.'s (DocuSign®) Digital Transaction Management (DTM) platform with industry-leading eSignature solution is the first-of-its-kind to be certified as compliant with the international SAFE-BioPharma® digital identity and signature standard.
AVOIDING THE ANTHEM DATA SECURITY BREACH
Teaneck, NJ (February 10, 2015) – Anthem's security breach may have been prevented or minimized had company policy required tighter control of its cyber-identity credentials. This is the opinion of several IT security leaders associated with the pharmaceutical industry.